Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.125EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
G.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.438EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.197EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.491EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.8 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.327EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.129EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.224EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.618EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.458EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.619.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.12.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.260EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.456EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used